Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

OPKO Health Inc. (OPK)

3.875   0.075 (1.97%) 09-23 13:14
Open: 3.8 Pre. Close: 3.8
High: 3.88 Low: 3.78
Volume: 758,284 Market Cap: 2,640M
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.874 - 3.89 3.89 - 3.903
Low: 3.738 - 3.756 3.756 - 3.773
Close: 3.787 - 3.818 3.818 - 3.845

Technical analysis

as of: 2021-09-23 12:43:42 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.63     One year: 5.41
Support: Support1: 3.64    Support2: 3.44
Resistance: Resistance1: 3.96    Resistance2: 4.63
Pivot: 3.72
Moving Average: MA(5): 3.83     MA(20): 3.75
MA(100): 3.74     MA(250): 4.14
MACD: MACD(12,26): 0.02     Signal(9):
Stochastic oscillator: %K(14,3): 69.21     %D(3): 76.07
RSI: RSI(14): 52.90
52-week: High: 6.27  Low: 3.02  Change(%): 23.8
Average Vol(K): 3-Month: 11278259  10-Days: 419447

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
OPK has closed below upper band by 34.8%. Bollinger Bands are 3.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 20 Sep 2021
Opko Health (OPK) falls 3.81% to Close at $3.79 on September 20 -

Mon, 20 Sep 2021
What You Need To Know About OPKO Health, Inc.'s (NASDAQ:OPK) Investor Composition - Nasdaq

Wed, 15 Sep 2021
Analyst Rating: Will Opko Health Inc. (OPK) Stock Beat the Market? - InvestorsObserver

Wed, 15 Sep 2021
OPKO Health (OPK) Forms JV, Establishes Presence in China - Entrepreneur

Tue, 14 Sep 2021
Opko Health (OPK) falls 2.79% in Light Trading on September 14 -

Mon, 13 Sep 2021
Should You Hold Opko Health Inc. (OPK) Stock Monday Morning? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 689
Shares Float (M) 388
% Held by Insiders 40.35
% Held by Institutions 29.53
Shares Short (K) 57,100
Shares Short P. Month (K) 79,650

Stock Financials

EPS 0.189
EPS Est This Year -0.190
EPS Est Next Year -0.080
Book Value (p.s.) 2.530
Profit Margin 6.83
Operating Margin 7.51
Return on Assets (ttm) 3.5
Return on Equity (ttm) 7.4
Qtrly Rev. Growth 157.8
Gross Profit (p.s.) 0.785
Sales Per Share 2.568
EBITDA (p.s.) 0.314
Qtrly Earnings Growth
Operating Cash Flow (M) 109
Levered Free Cash Flow (M) 11

Stock Valuations

PE Ratio 20.11
PEG Ratio
Price to Book value 1.50
Price to Sales 1.48
Price to Cash Flow 24.05

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.